ProName: ab-chminaca Ibrutinib
Molecular Formula: N/A
PackAge: 10g; 100g;1kg; 25kg
Storage: in stock
Transportation: DHL; FEDEX; TNT and aircargo
Our product is a targeted agent that selectively inhibits Bruton-tyrosine kinase (BTK), an important mediator of at least three key B cell survival mechanisms. This multiple action of Bruton's tyrosine kinase allows it to direct B-cell malignancies into the lymphoid tissue, allowing the tumor cells to survive the necessary microenvironment. The US Food and Drug Administration (FDA) has granted Ibrutinib a "breakthrough" status for the treatment of two B-cell malignancies: recurrent or refractory mantle cell lymphoma (MCL; previously treated patients) (WM)
We are a professional manufacturer pharmaceutical intermediate with more than 8 years export experience.
Welcome to contact us:
We are adhering to the consistent good commercial reputation, to create a highly efficient, high quality of chemical research, development, production, sales and service of integrated platform, to make our customers easy to order.
All of our company is committed to provide high quality chemicals, competitive price, best service, fast shipping and stable supply to our loyal customers.
We are pleasure to establish a long term business relationship with you.
We could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. mature Technical support
4. Professional logistic support
5 . Full experience of large numbers containers loading in Chinese sea port
6 Fast shipment by reputed shipping line
7. Packing with pallet as buyer's special request
8. Best service after shipment.
9. Cargoes together with container after-sales service available
10. Full experience in export
11. Raw materials from Chinese origin
Welcome!!!. Send yr. inquiries, you will get it!